Literature DB >> 31952957

Esketamine as a treatment for paediatric depression: questions of safety and efficacy.

Kelsey S Zimmermann1, Rick Richardson2, Kathryn D Baker2.   

Abstract

Entities:  

Year:  2020        PMID: 31952957     DOI: 10.1016/S2215-0366(19)30521-8

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN: 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  2 in total

1.  How to deprescribe esketamine in resistant depression? A point of view after first clinical uses.

Authors:  T Taillefer de Laportalière; A Yrondi; A Jullien; P Cestac; F Montastruc
Journal:  Epidemiol Psychiatr Sci       Date:  2022-01-11       Impact factor: 6.892

Review 2.  Novel Pharmacological Approaches to the Treatment of Depression.

Authors:  Elias Elias; Ariel Y Zhang; Melissa T Manners
Journal:  Life (Basel)       Date:  2022-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.